Skip to main content
H.R. 5343 House Health

Ensuring Patient Access to Critical Breakthrough Products Act

Introduced
Sep 15, 2025
Sponsor
Rep. Moore, Blake D. (R-UT-1)
View on Congress.gov (opens in a new tab)

STAGE 2 OF 8 — COMMITTEE CONSIDERATION

Currently in the House. Last action: ordered to be reported in the nature of a substitute (amended) by the yeas and nays: 37 - 3 on Sep 17, 2025.

  1. House Introduced in House Sep 15, 2025
  2. House Referred to the Committee on Ways and Means, and in addition to the Committee on Energy and Commerce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. Sep 15, 2025
  3. House Committee Consideration and Mark-up Session Held Sep 17, 2025
  4. House Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 37 - 3. Sep 17, 2025

Cosponsors

51

Subjects

Congressional oversightDrug safety, medical device, and laboratory regulationHealth care costs and insuranceHealth care coverage and accessHealth programs administration and fundingHealth technology, devices, suppliesMedicare

Committees

  • Ways and Means Committee
    • Markup By , Sep 17, 2025
    • Referred To , Sep 15, 2025
  • Energy and Commerce Committee
    • Referred To , Sep 15, 2025

Summary

No summary available.

Comments · 0

Loading...

Loading comments...